Related Experiment Video
Updated: Sep 30, 2026

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
Published on: February 19, 2021
Progressive ventricular enlargement in patients with clinically isolated syndromes is associated with the early
C M Dalton1, P A Brex, R Jenkins
1NMR Research Unit, Institute of Neurology, London, UK.
Background:
In patients with clinically isolated syndromes (CIS) suggestive of multiple sclerosis (MS), the extent of brain magnetic resonance imaging (MRI) lesion load influences the probability and time to development of clinically definite MS. Cerebral atrophy is recognised in established MS, but its time of onset and whether, in early disease, it is related to MRI lesion load or clinical outcome is less certain.
Objectives:
This study investigated ventricular enlargement over one year in CIS patients and explored its relation with lesion load and clinical outcome.
Methods:
A semi-automated thresholding technique for measuring ventricular volume (MIDAS) was applied to MRI scans in a cohort of 55 patients with CIS, recruited consecutively and imaged within three months of the onset of symptoms and again after one year.
Results:
Clinical MS had developed after one year in 16 of 40 patients with an abnormal baseline T2 scan and 2 of 15 with a normal scan. Significant ventricular enlargement was seen in 27 of 55 patients who fulfilled the new McDonald MRI criteria for MS using all available MRI at clinical follow up (median increase 0.3 cm(3), p=0.005) Significant increase in ventricular volume was also seen in the 18 of 55 patients who developed clinical MS over the follow up period (median increase 0.5 cm(3), p=0.006). There were significant but modest correlations between baseline lesion measures and subsequent ventricular enlargement.
Conclusions:
(1) Lesions and atrophy are both associated with early relapse leading to a diagnosis of clinical MS; (2) while lesions contribute to the development of atrophy, atrophy may also develop by other mechanisms. This suggests that MR measures have a complementary role in monitoring the course of MS, even from the earliest clinical stage.
Insights
Brain atrophy and lesion load are linked to early multiple sclerosis (MS) development in patients with clinically isolated syndromes (CIS). MRI measures can help monitor early MS progression.
Area of Science:
- Neurology
- Radiology
- Neuroimmunology
Background:
- Clinically isolated syndromes (CIS) can precede multiple sclerosis (MS).
- Brain lesion load on MRI predicts MS development in CIS patients.
- Cerebral atrophy in early MS is not well understood regarding onset and relation to lesion load or clinical outcomes.
Purpose of the Study:
- Investigate ventricular enlargement over one year in CIS patients.
- Explore the relationship between ventricular enlargement, MRI lesion load, and clinical outcomes in early MS.
Main Methods:
- A cohort of 55 CIS patients were recruited and imaged using MRI within three months of symptom onset and again after one year.
- A semi-automated thresholding technique (MIDAS) was used to measure ventricular volume from MRI scans.
- Patients were assessed for the development of clinically definite MS and fulfillment of McDonald MRI criteria.
Main Results:
- 16 of 40 patients with abnormal baseline T2 scans developed clinical MS within one year.
- Significant ventricular enlargement occurred in 27 of 55 patients meeting MS criteria, with a median increase of 0.3 cm³.
- Significant ventricular volume increase was observed in 18 of 55 patients who developed clinical MS, with a median increase of 0.5 cm³.
- Modest correlations were found between baseline lesion measures and subsequent ventricular enlargement.
Conclusions:
- Both MRI-detected lesions and cerebral atrophy are associated with early relapse and diagnosis of clinical MS.
- While MS lesions contribute to atrophy, other mechanisms may also drive its development.
- MRI measures play a complementary role in monitoring MS progression, even in its earliest stages.
Related Concept Videos
Multiple Sclerosis l: Introduction
Cardiomyopathy II: Dilated Cardiomyopathy
Mitral Stenosis I: Introduction
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Heart Failure II: Pathophysiology

